Literature DB >> 11256613

The EXT1/EXT2 tumor suppressors: catalytic activities and role in heparan sulfate biosynthesis.

C Senay1, T Lind, K Muguruma, Y Tone, H Kitagawa, K Sugahara, K Lidholt, U Lindahl, M Kusche-Gullberg.   

Abstract

The D-glucuronyltransferase and N-acetyl-D-glucosaminyltransferase reactions in heparan sulfate biosynthesis have been associated with two genes, EXT1 and EXT2, which are also implicated in the inherited bone disorder, multiple exostoses. Since the cell systems used to express recombinant EXT proteins synthesize endogenous heparan sulfate, and the EXT proteins tend to associate, it has not been possible to define the functional roles of the individual protein species. We therefore expressed EXT1 and EXT2 in yeast, which does not synthesize heparan sulfate. The recombinant EXT1 and EXT2 were both found to catalyze both glycosyltransferase reactions in vitro. Coexpression of the two proteins, but not mixing of separately expressed recombinant EXT1 and EXT2, yields hetero-oligomeric complexes in yeast and mammalian cells, with augmented glycosyltransferase activities. This stimulation does not depend on the membrane-bound state of the proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11256613      PMCID: PMC1083719          DOI: 10.1093/embo-reports/kvd045

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  14 in total

1.  The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate.

Authors:  C McCormick; G Duncan; K T Goutsos; F Tufaro
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  Hedgehog movement is regulated through tout velu-dependent synthesis of a heparan sulfate proteoglycan.

Authors:  I The; Y Bellaiche; N Perrimon
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

Review 3.  Regulated diversity of heparan sulfate.

Authors:  U Lindahl; M Kusche-Gullberg; L Kjellén
Journal:  J Biol Chem       Date:  1998-09-25       Impact factor: 5.157

4.  Small vectors for expression based on dominant drug resistance with direct multicopy selection.

Authors:  D R Higgins; K Busser; J Comiskey; P S Whittier; T J Purcell; J P Hoeffler
Journal:  Methods Mol Biol       Date:  1998

5.  A direct interaction between EXT proteins and glycosyltransferases is defective in hereditary multiple exostoses.

Authors:  A D Simmons; M M Musy; C S Lopes; L Y Hwang; Y P Yang; M Lovett
Journal:  Hum Mol Genet       Date:  1999-11       Impact factor: 6.150

6.  The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate.

Authors:  C McCormick; Y Leduc; D Martindale; K Mattison; L E Esford; A P Dyer; F Tufaro
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

7.  Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1).

Authors:  J Ahn; H J Lüdecke; S Lindow; W A Horton; B Lee; M J Wagner; B Horsthemke; D E Wells
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

Review 8.  Overview of N- and O-linked oligosaccharide structures found in various yeast species.

Authors:  T R Gemmill; R B Trimble
Journal:  Biochim Biophys Acta       Date:  1999-01-06

9.  Cloning of a novel alpha 2,3-sialyltransferase that sialylates glycoprotein and glycolipid carbohydrate groups.

Authors:  H Kitagawa; J C Paulson
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

10.  The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate.

Authors:  T Lind; F Tufaro; C McCormick; U Lindahl; K Lidholt
Journal:  J Biol Chem       Date:  1998-10-09       Impact factor: 5.157

View more
  49 in total

1.  Enzyme interactions in heparan sulfate biosynthesis: uronosyl 5-epimerase and 2-O-sulfotransferase interact in vivo.

Authors:  M A Pinhal; B Smith; S Olson; J Aikawa; K Kimata; J D Esko
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

Review 2.  The link between heparan sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins.

Authors:  G Duncan; C McCormick; F Tufaro
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

3.  A mouse model of chondrocyte-specific somatic mutation reveals a role for Ext1 loss of heterozygosity in multiple hereditary exostoses.

Authors:  Kazu Matsumoto; Fumitoshi Irie; Susan Mackem; Yu Yamaguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

4.  Involvement of chondroitin sulfate synthase-3 (chondroitin synthase-2) in chondroitin polymerization through its interaction with chondroitin synthase-1 or chondroitin-polymerizing factor.

Authors:  Tomomi Izumikawa; Toru Uyama; Yuka Okuura; Kazuyuki Sugahara; Hiroshi Kitagawa
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

Review 5.  Genetic alterations in chondrosarcomas - keys to targeted therapies?

Authors:  Andre M Samuel; Jose Costa; Dieter M Lindskog
Journal:  Cell Oncol (Dordr)       Date:  2014-01-24       Impact factor: 6.730

Review 6.  The nematode Caenorhabditis elegans as a model to study the roles of proteoglycans.

Authors:  Patricia M Berninsone; Carlos B Hirschberg
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

Review 7.  Human genetic disorders caused by mutations in genes encoding biosynthetic enzymes for sulfated glycosaminoglycans.

Authors:  Shuji Mizumoto; Shiro Ikegawa; Kazuyuki Sugahara
Journal:  J Biol Chem       Date:  2013-03-01       Impact factor: 5.157

8.  A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes.

Authors:  Kevin B Jones; Virginia Piombo; Charles Searby; Gail Kurriger; Baoli Yang; Florian Grabellus; Peter J Roughley; Jose A Morcuende; Joseph A Buckwalter; Mario R Capecchi; Andrea Vortkamp; Val C Sheffield
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

9.  Activation of beta1,3-N-acetylglucosaminyltransferase-2 (beta3Gn-T2) by beta3Gn-T8. Possible involvement of beta3Gn-T8 in increasing poly-N-acetyllactosamine chains in differentiated HL-60 cells.

Authors:  Akira Seko; Katsuko Yamashita
Journal:  J Biol Chem       Date:  2008-09-30       Impact factor: 5.157

10.  Malignant progression in two children with multiple osteochondromas.

Authors:  Gregory A Schmale; Douglas S Hawkins; Joe Rutledge; Ernest U Conrad
Journal:  Sarcoma       Date:  2010-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.